Protein C, protein S, and thrombomodulin in amniotic fluid. A preliminary study

Journal of Perinatal Medicine

Volumn 34, Issue 4, 2006, Pages 289-292

  Uszyński, Mieczysław ^a   Zekanowska, Ewa ^a   Kotzbach, Marcin ^b   Uszyński, Waldemar ^c   Kotzbach, Roman ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Private Medical Center   (Poland)

^c Regional Hospital   (Poland)

Author keywords

Amniotic fluid; Protein C; Protein S; Thrombomodulin

Indexed keywords

ANTIGEN; PROTEIN C; PROTEIN S; THROMBOMODULIN;

ADULT; AMNION FLUID; AMNION FLUID ANALYSIS; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LABOR; MOTHER; PLASMA; PREGNANCY; PRIORITY JOURNAL;

ADULT; AMNIOTIC FLUID; BLOOD COAGULATION; CASE-CONTROL STUDIES; FEMALE; HUMANS; LABOR STAGE, FIRST; PREGNANCY; PROTEIN C; PROTEIN S; THROMBOMODULIN;

EID: 33746340870     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2006.055     Document Type: Article

References (20)

1. Boffa M-C, L Valsecchi, A Fausto, D Gozin, KS D'Angelo, O Safa, et al.: Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. Thromb Haemost 79 (1998) 1092
2. Clark P, A Greer, D Walker: Interaction of the protein C/protein S anticoagulant system, the endothelium and pregnancy. Blood Rev 15 (1999) 127
3. Esmon Ch: The endothelial cell protein C receptor. Thromb Haemost 83 (2000) 639
4. Faught W, P Garner, G Jones, B Ivey: Changes in protein C and protein S levels in normal pregnancy. Am J Obstet Gynecol 172 (1995) 147
5. Fazel A, A Vincenot, A Malassine, et al.: Increase in expression and activity of thrombomodulin in term human placenta syncytiotrophoblast microvilli. Placenta 19 (1998) 261
6. Isermann B, SB Hendricson, K Hutley, M Wing, H Weiler: Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block. Development 128 (2001) 850
7. Kupferminc MJ, M Eldor, N Steinman: Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340 (1999) 9
8. Lanir N, A Aharon, B Brenner: Procoagulant and anticoagulant mechanisms in human placenta. Semin Thromb Heamost 29 (2003) 175
9. Lockwood ChJ, R Bach, A Guha, et al.: Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol 165 (1991) 1335
10. de Moerloose P, N Mermillod, J Amiral, G Reber: Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1. Thromb Haemost 79 (1998) 554
11. Moniwa N: Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta. Pol J Pharmacol 48 (1996) 215
12. Mousa HA, C Doweney, Z Alfirevic, Ch-H Toh: Thrombin activatable fibrinolysis inhibitor and its fibrinolytic effect in normal pregnancy. Thromb Haemost 92 (2004) 1025
13. Thompson AR: Factor IX and prothrombin in amniotic fluid and fetal plasma: constraints on prenatal diagnosis of hemofilia B and evidence of proteolysis. Blood 64 (1984) 867
14. Queenan J, E Gadow, P Bachner, S Kubarych: A proteins in normal and RH-sensitized pregnancies. Am J Obstet Gynecol 108 (1970) 406
15. Takahashi H, S Ito, M Hanano, et al.: Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator. Am J Hematol 41 (1992) 32
16. Uszyński M, W Uszyński, A Kiełkowski: Tissue plasminogen activator and plasminogen activator inhibitors of types 1 and 2 in amniotic fluid before labor and childbirth. Gynecol Obstet Invest 39 (1995) 93
17. Uszyński M, A Kiełkowski, W Uszyński, E Żekanowska: Thrombin- antithrombin III complexes and antithrombin III in amniotic fluid. Gynecol Obstet Invest 43 (1997) 29
18. Uszyński M, A Kłyszejko, E Żekanowska: Plasminogen, alfa-2-antiplasmin and complexes of plasmin-alfa 2-antiplasmin (PAP) in amniotic fluid and blood plasma of parturient women. Eur J Obstet Gynecol Rep Biol 93 (2000) 167
19. Uszyński M, E Żekanowska, W Uszyński, J Kuczyński: Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implicatios for the mechanism of amniotic fluid embolism. Eur J Obstet Gynecol Rep Biol 95 (2001) 163
20. Walker MC, PR Garner, EJ Keely, GA Rock, MD Reis: Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol 177 (1997) 162